×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABCL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
10:20 pm
abcl
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
11/26
04:31 pm
abcl
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]
11/18
06:32 am
abcl
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]
Low
Report
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]
11/10
10:57 am
abcl
The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
Low
Report
The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
11/10
09:00 am
abcl
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
Medium
Report
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
11/9
05:03 am
abcl
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]
Medium
Report
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]
11/8
06:57 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
04:05 pm
ABCL
abcellera biologics inc. - common shares
MISS
Report
-13.5%
abcellera biologics inc. - common shares
8/7/2025
04:05 pm
ABCL
abcellera biologics inc. - common shares
BEAT
Report
-0.2%
abcellera biologics inc. - common shares
5/8/2025
04:05 pm
ABCL
abcellera biologics inc. - common shares
BEAT
Report
1.0%
abcellera biologics inc. - common shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/28
02:21 pm
abcl
Form 8-K AbCellera Biologics Inc. For: Nov 24
Neutral
Report
Form 8-K AbCellera Biologics Inc. For: Nov 24
11/26
02:58 pm
abcl
Form 4 AbCellera Biologics Inc. For: Nov 26 Filed by: Montalbano John S.
Low
Report
Form 4 AbCellera Biologics Inc. For: Nov 26 Filed by: Montalbano John S.
11/12
01:47 pm
abcl
Form 8-K AbCellera Biologics Inc. For: Nov 10
Low
Report
Form 8-K AbCellera Biologics Inc. For: Nov 10
11/6
04:29 pm
abcl
Form 10-Q AbCellera Biologics Inc. For: Sep 30
High
Report
Form 10-Q AbCellera Biologics Inc. For: Sep 30
11/6
04:23 pm
abcl
Form 8-K AbCellera Biologics Inc. For: Nov 06
High
Report
Form 8-K AbCellera Biologics Inc. For: Nov 06
9/10
12:23 pm
abcl
Form 8-K AbCellera Biologics Inc. For: Sep 10
Low
Report
Form 8-K AbCellera Biologics Inc. For: Sep 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: